259 related articles for article (PubMed ID: 28332780)
1. Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment.
Saengnipanthkul S; Waikakul S; Rojanasthien S; Totemchokchyakarn K; Srinkapaibulaya A; Cheh Chin T; Mai Hong N; Bruyère O; Cooper C; Reginster JY; Lwin M
Int J Rheum Dis; 2019 Mar; 22(3):376-385. PubMed ID: 28332780
[TBL] [Abstract][Full Text] [Related]
2. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes.
Kucharz EJ; Kovalenko V; Szántó S; Bruyère O; Cooper C; Reginster JY
Curr Med Res Opin; 2016 Jun; 32(6):997-1004. PubMed ID: 26881468
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
Bruyère O; Altman RD; Reginster JY
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S12-7. PubMed ID: 26806187
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Bruyère O; Cooper C; Al-Daghri NM; Dennison EM; Rizzoli R; Reginster JY
Aging Clin Exp Res; 2018 Feb; 30(2):111-117. PubMed ID: 29177637
[TBL] [Abstract][Full Text] [Related]
5. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting.
Bruyère O; Cooper C; Pelletier JP; Maheu E; Rannou F; Branco J; Luisa Brandi M; Kanis JA; Altman RD; Hochberg MC; Martel-Pelletier J; Reginster JY
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S3-11. PubMed ID: 26806188
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
Rovati LC; Girolami F; D'Amato M; Giacovelli G
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S34-41. PubMed ID: 26632505
[TBL] [Abstract][Full Text] [Related]
7. Role of glucosamine in the treatment for osteoarthritis.
Reginster JY; Neuprez A; Lecart MP; Sarlet N; Bruyere O
Rheumatol Int; 2012 Oct; 32(10):2959-67. PubMed ID: 22461188
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis.
Qiu GX; Gao SN; Giacovelli G; Rovati L; Setnikar I
Arzneimittelforschung; 1998 May; 48(5):469-74. PubMed ID: 9638313
[TBL] [Abstract][Full Text] [Related]
9. Use of a glycosamine sulfate for patients with osteoarthritis and a comorbidity with high risk of the side effects from NSAIDS.
Naumov AV; Tkacheva ON
Ter Arkh; 2018 May; 90(5):81-87. PubMed ID: 30701895
[TBL] [Abstract][Full Text] [Related]
10. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.
Bernetti A; Mangone M; Villani C; Alviti F; Valeo M; Grassi MC; Migliore A; Viora U; Adriani E; Quirino N; Fioravanti A; Paoloni M
Eur J Phys Rehabil Med; 2019 Oct; 55(5):658-664. PubMed ID: 31106560
[TBL] [Abstract][Full Text] [Related]
11. [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].
Aubry-Rozier B
Rev Med Suisse; 2012 Mar; 8(332):571-2, 574, 576. PubMed ID: 22455150
[TBL] [Abstract][Full Text] [Related]
12. A retrospective observational study of glucosamine sulfate in addition to conventional therapy in hand osteoarthritis patients compared to conventional treatment alone.
Tenti S; Giordano N; Mondanelli N; Giannotti S; Maheu E; Fioravanti A
Aging Clin Exp Res; 2020 Jun; 32(6):1161-1172. PubMed ID: 31429006
[TBL] [Abstract][Full Text] [Related]
13. Expert Opinion on the Extensive Use of Prescription Crystalline Glucosamine Sulfate in the Multimodal Treatment of Osteoarthritis in Ukraine, Kazakhstan, Uzbekistan, and Armenia.
Gnylorybov AM; Ter-Vartanian SK; Golovach IY; Vyrva OE; Burianov OA; Yesirkepova GS; Irismetov ME; Rizamuhamedova MZ; Vardanyan VS; Ginosyan KV
Clin Med Insights Arthritis Musculoskelet Disord; 2020; 13():1179544120946743. PubMed ID: 32821188
[TBL] [Abstract][Full Text] [Related]
14. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?
Henrotin Y; Mobasheri A; Marty M
Arthritis Res Ther; 2012 Jan; 14(1):201. PubMed ID: 22293240
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness Assessment of Different Glucosamines in Patients with Knee Osteoarthritis: A Simulation Model Adapted to Germany.
Bruyère O; Detilleux J; Reginster JY
Curr Aging Sci; 2021; 14(3):242-248. PubMed ID: 33858318
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
17. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.
Deal CL; Moskowitz RW
Rheum Dis Clin North Am; 1999 May; 25(2):379-95. PubMed ID: 10356424
[TBL] [Abstract][Full Text] [Related]
18. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS).
Laba TL; Brien JA; Fransen M; Jan S
BMC Musculoskelet Disord; 2013 May; 14():160. PubMed ID: 23647688
[TBL] [Abstract][Full Text] [Related]
19. Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
Gregori D; Giacovelli G; Minto C; Barbetta B; Gualtieri F; Azzolina D; Vaghi P; Rovati LC
JAMA; 2018 Dec; 320(24):2564-2579. PubMed ID: 30575881
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of osteoarthritis crystalline glucosamine sulphate/a review of the clinical effcacy].
Heisel J; Förster KK
Arzneimittelforschung; 2007; 57(4):203-17. PubMed ID: 17515291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
